Indus Towers Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:06 am

Competitors of Indus Towers Ltd

All Competitor Stocks of Indus Towers Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:55 pm

Below is a detailed analysis of the quarterly data for Indus Towers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 8,058.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,727.00 Cr. (Mar 2025) to 8,058.00 Cr., marking an increase of 331.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,668.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,332.00 Cr. (Mar 2025) to 3,668.00 Cr., marking an increase of 336.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 4,390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,395.00 Cr. (Mar 2025) to 4,390.00 Cr., marking a decrease of 5.00 Cr..
• For OPM %, as of Jun 2025, the value is 54.00%. The value appears to be declining and may need further review. It has decreased from 57.00% (Mar 2025) to 54.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 92.00 Cr. (Mar 2025) to 85.00 Cr., marking a decrease of 7.00 Cr..
• For Interest, as of Jun 2025, the value is 437.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 431.00 Cr. (Mar 2025) to 437.00 Cr., marking an increase of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1,704.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,693.00 Cr. (Mar 2025) to 1,704.00 Cr., marking an increase of 11.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 2,334.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,363.00 Cr. (Mar 2025) to 2,334.00 Cr., marking a decrease of 29.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 1,737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,779.00 Cr. (Mar 2025) to 1,737.00 Cr., marking a decrease of 42.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.44. The value appears to be declining and may need further review. It has decreased from 6.60 (Mar 2025) to 6.44, marking a decrease of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:37 am

Growth

Last Updated: September 5, 2025, 3:01 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Indus Towers Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 37.31. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.31, marking an increase of 14.91.
• For Diluted EPS (Rs.), as of Mar 25, the value is 37.31. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.31, marking an increase of 14.91.
• For Cash EPS (Rs.), as of Mar 25, the value is 61.91. This value is within the healthy range. It has increased from 44.88 (Mar 24) to 61.91, marking an increase of 17.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.19. It has increased from 100.33 (Mar 24) to 123.19, marking an increase of 22.86.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 123.19. It has increased from 100.33 (Mar 24) to 123.19, marking an increase of 22.86.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 114.18. It has increased from 106.13 (Mar 24) to 114.18, marking an increase of 8.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 81.17. This value is within the healthy range. It has increased from 55.35 (Mar 24) to 81.17, marking an increase of 25.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 56.90. This value is within the healthy range. It has increased from 32.87 (Mar 24) to 56.90, marking an increase of 24.03.
• For PBT / Share (Rs.), as of Mar 25, the value is 49.86. This value is within the healthy range. It has increased from 30.14 (Mar 24) to 49.86, marking an increase of 19.72.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 37.65. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.65, marking an increase of 15.25.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 37.65. This value is within the healthy range. It has increased from 22.40 (Mar 24) to 37.65, marking an increase of 15.25.
• For PBDIT Margin (%), as of Mar 25, the value is 71.08. This value is within the healthy range. It has increased from 52.15 (Mar 24) to 71.08, marking an increase of 18.93.
• For PBIT Margin (%), as of Mar 25, the value is 49.83. This value exceeds the healthy maximum of 20. It has increased from 30.97 (Mar 24) to 49.83, marking an increase of 18.86.
• For PBT Margin (%), as of Mar 25, the value is 43.66. This value is within the healthy range. It has increased from 28.39 (Mar 24) to 43.66, marking an increase of 15.27.
• For Net Profit Margin (%), as of Mar 25, the value is 32.97. This value exceeds the healthy maximum of 10. It has increased from 21.10 (Mar 24) to 32.97, marking an increase of 11.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 32.97. This value exceeds the healthy maximum of 20. It has increased from 21.10 (Mar 24) to 32.97, marking an increase of 11.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 30.56. This value is within the healthy range. It has increased from 22.32 (Mar 24) to 30.56, marking an increase of 8.24.
• For Return on Capital Employeed (%), as of Mar 25, the value is 28.12. This value is within the healthy range. It has increased from 19.37 (Mar 24) to 28.12, marking an increase of 8.75.
• For Return On Assets (%), as of Mar 25, the value is 15.72. This value is within the healthy range. It has increased from 10.80 (Mar 24) to 15.72, marking an increase of 4.92.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.06, marking a decrease of 0.09.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has decreased from 0.55 (Mar 24) to 0.50, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.32, marking an increase of 0.29.
• For Quick Ratio (X), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.32, marking an increase of 0.29.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 11.53. This value is within the healthy range. It has decreased from 20.29 (Mar 24) to 11.53, marking a decrease of 8.76.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.35. This value is within the healthy range. It has decreased from 9.21 (Mar 24) to 6.35, marking a decrease of 2.86.
• For Enterprise Value (Cr.), as of Mar 25, the value is 88,545.22. It has increased from 82,710.71 (Mar 24) to 88,545.22, marking an increase of 5,834.51.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has increased from 2.89 (Mar 24) to 2.94, marking an increase of 0.05.
• For EV / EBITDA (X), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 5. It has decreased from 5.54 (Mar 24) to 4.13, marking a decrease of 1.41.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.74 (Mar 24) to 2.93, marking an increase of 0.19.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has decreased from 2.90 (Mar 24) to 2.71, marking a decrease of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.93. This value is within the healthy range. It has increased from 2.74 (Mar 24) to 2.93, marking an increase of 0.19.
• For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.11, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness